PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Medicine, Università Cattolica del Sacro Cuore, Roma, Italy.\', \'Division of Rheumatology, Fondazione Policlinico Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.\', \'National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.\', \'Rheumatology Department, Azienda USL Toscana Centro, Prato Hospital, Prato, Italy.\', \'Immunology Section, Department of Medicine, University and Hospital Trust of Verona, Verona, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1158/2326-6066.CIR-21-0675
?:hasPublicationType
?:journal
  • Cancer immunology research
is ?:pmid of
?:pmid
?:pmid
  • 35074758
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.956
?:rankingScore_hIndex
  • 46
is ?:relation_isRelatedTo_publication of
?:title
  • Immune-Guided Therapy of COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35074758>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35074758>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all